BRIEF-Alkermes submits supplemental new drug application to FDA
 

BRIEF-Alkermes submits supplemental new drug application to FDA
* Alkermes submits supplemental new drug application to FDAfor two month dosing option of Aristada for treatment ofschizophreniahttp://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...ik:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...ik:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/xxKivQ07s1g